Aarti Drugs Ltd
Next 500 2024
+ 9 More
+ 9 More
Share
Share
OVERVIEW
FINANCIALS
NEWS
About
Aarti Drugs is a leading Indian pharmaceutical company engaged in the manufacturing of active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. They serve various therapeutic segments such as antibiotics, anti-protozoal, and anti-inflammatory. Their focus on quality and compliance has established them as a trusted supplier in both domestic and international markets.
Incorporation Year: 1984
Headquarters: Mumbai, India
Top Management: Rashesh C. Gogri (MD)
Industry: Pharma
Website: www.aartidrugs.co.in
Featured In Fortune India Ranking
Fortune 500 India
#467(2021)
#467(2021)
Next 500 India
#110(2024)#25(2023)#8(2021)#127(2020)#157(2019)#199(2018)#212(2017)#189(2016)#320(2015)
#110(2024)#25(2023)#8(2021)#127(2020)#157(2019)#199(2018)#212(2017)#189(2016)#320(2015)
Financial Data 2024
Revenue
2,507
(INR Cr)
Net Operating Income
2,529
(INR Cr)
Assets
1,849
(INR Cr)
Profit
171
(INR Cr)
Net Worth
1,282
(INR Cr)
Fortune India Coverage
Financial Data
RevenueNet Operating IncomeProfitAssetsNet Worth
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 2507 -7.8% | 2720 5.2% | 2586 18.9% | 2174 16.7% | 1863 20.2% | 1550 19.3% | 1300 8.3% | 1200 4.8% | 1145 1.8% | 1125 16.3% | 967 14.1% | 848 27.8% | 663 27.6% | 520 9.2% | 476 27.4% | 374 - |
| Net Operating Income (INR Cr) | 2529 -6.90% | 2716 9.14% | 2489 15.49% | 2155 19.31% | 1806 15.71% | 1561 25.51% | 1244 4.05% | 1195 4.85% | 1140 3.92% | 1097 0.00% | 972 17.68% | 826 25.25% | 659 32.80% | 501 4.71% | 479 25.23% | 382 22.33% |
| Profit (INR Cr) | 171 3.1% | 166 -18.9% | 205 -26.9% | 280 98.3% | 141 57.6% | 90 9.0% | 82 0.6% | 82 19.0% | 69 -11.0% | 77 25.2% | 62 36.4% | 45 101.4% | 22 -5.6% | 24 -15.8% | 28 74.9% | 16 - |
| Assets (INR Cr) | 1849 2.5% | 1805 13.0% | 1598 23.6% | 1293 20.3% | 1075 0.1% | 1074 4.2% | 1030 14.1% | 903 5.9% | 853 11.0% | 769 27.1% | 605 17.1% | 516 13.0% | 457 6.0% | 431 26.6% | 340 4.6% | 325 - |
| Net Worth (INR Cr) | 1282 7.5% | 1192 15.1% | 1036 13.5% | 913 40.0% | 652 20.1% | 543 19.3% | 455 13.8% | 400 12.0% | 357 16.0% | 308 0.0% | 251 20.9% | 208 17.6% | 176 12.8% | 163 11.4% | 146 18.6% | 123 10.7% |
| Employee Cost (INR Cr) | 91 12.6% | 80 16.1% | 69 5.2% | 66 7.4% | 61 12.5% | 55 4.6% | 52 8.7% | 48 19.3% | 40 20.8% | 33 16.7% | 29 10.2% | 26 11.1% | 23 16.8% | 20 34.9% | 15 23.2% | 12 - |
| Interest Cost (INR Cr) | 38 | 37 | 24 | 26 | 37 | 44 | 38 | 40 | 48 | 42 | 37 | 31 | 25 | 17 | 19 | 26 |
| Cash & Bank Balance (INR Cr) | 9 | 9 | 22 | 10 | 8 | 6 | 4 | 4 | 5 | 4 | 4 | 3 | 5 | 5 | 9 | 3 |
| Total Debt (INR Cr) | 564 | 609 | 543 | 351 | 389 | 507 | 546 | 480 | 483 | 448 | 342 | 296 | 272 | 267 | 189 | 192 |
Key Financial Ratios
Profit As % Of RevenuesRONW %Interest Cost to EBITDA %ROCE %Debt to Equity Ratio
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 6.8% | 6.1% | 7.9% | 12.9% | 7.6% | 5.8% | 6.3% | 6.8% | 6.0% | 6.9% | 6.4% | 5.3% | 3.4% | 4.6% | 5.9% | 4.3% |
| Profit As % Of Assets | 9.3% | 9.2% | 12.8% | 21.7% | 13.2% | 8.4% | 8.0% | 9.1% | 8.1% | 10.1% | 10.2% | 8.8% | 4.9% | 5.5% | 8.3% | 5.0% |
| Profit As % Of Networth | 13.4% | 14.0% | 19.8% | 30.7% | 21.7% | 16.5% | 18.1% | 20.4% | 19.2% | 25.1% | 24.6% | 21.8% | 12.7% | 14.6% | 19.3% | 13.1% |
| Interest Cost to EBITDA % | 11.8% | 12.0% | 7.2% | 6.0% | 14.1% | 20.6% | 19.0% | 21.0% | 26.7% | 24.5% | 24.8% | 25.1% | 32.2% | 24.8% | 22.6% | 39.8% |
| Debt to Equity Ratio | 0.44 | 0.51 | 0.52 | 0.38 | 0.60 | 0.93 | 1.20 | 1.20 | 1.35 | 1.45 | 1.36 | 1.42 | 1.54 | 1.64 | 1.29 | 1.56 |
| RONW | 13.9% | 14.9% | 21.0% | 35.8% | 23.7% | 18.0% | 19.2% | 21.6% | 20.7% | 25.1% | 26.9% | 23.6% | 13.5% | 15.0% | 20.0% | 14.4% |
| ROCE | 15.0% | 15.4% | 20.3% | 33.4% | 20.7% | 16.6% | 16.9% | 17.8% | 17.7% | 19.3% | 21.9% | 19.9% | 13.7% | 13.0% | 19.9% | 16.1% |